DeepBio

Welcome to Deep Bio! We are a dynamic AI medical software company with a vision to transform and improve clinical diagnostics, and deliver the best quality of care for patients around the world.

September#ProstateCancerAwarenessMonth : Early detection saves lives. At Deep Bio, our AI algorithm supports pathologists ⠀ with faster, more accurate diagnoses let’s raise awareness and drive innovation in cancer care #MensHealth #ProstateCancer #AI

🎗️ July is Sarcoma & Bone Cancer Awareness Month! Let's spotlight leiomyosarcoma, sarcoma, and other rare bone cancers. Early detection & research are crucial. Deep Bio supports all fighters, patients, & healthcare pros, advancing #oncology with #AI#CancerAwareness 💪

🎗️June is Cancer Survivors Month – A Time to Honor Strength and Hope At Deep Bio, this month holds deep meaning. We honor the strength of cancer survivors—the individuals whose journeys inspire innovation, empathy, and relentless pursuit of better care.

🎗️ May is Bladder Cancer, Brain Tumor, Melanoma, and Skin Cancer Awareness Month 🎗️ At Deep Bio, we stand in solidarity with patients, caregivers, and the oncology community as we raise awareness for these critical cancer types.

🔬 May is Cancer Research Month! At Deep Bio, we’re pushing the boundaries of AI in digital pathology—advancing cancer detection, diagnostics, and patient outcomes. Explore our latest research 👉 deepbio.co.kr/media/ #CancerResearchMonth #AIinHealthcare #DigitalPathology

🌟 Deep Bio is headed to AACR 2025 in Chicago! 📍 Visit us at Booth #846 to explore how AI is transforming digital pathology — from biomarker analysis to diagnostic support. 📅 Scan the QR code to schedule a meeting, or drop by Booth #846. We’d love to connect.

Deep Bio is to present three of its latest studies at the upcoming AACR Annual Meeting in Chicago, IL. If you're attending AACR 2025, stop by our posters or booth#846 to learn more about how we’re applying AI to advance cancer diagnostics and immunohistochemistry interpretation.

🔬 Our USCAP 2025 presentation is now available On Demand! Join Deep Bio’s AI Engineer Joonyoung Cho for “Expansion of AI in Prostate Diagnostics: From Cancer to Atypical Large Glandular Proliferations.” 🎥 Watch the full talk: 2025am.uscap.org/ondemand (USCAP account required)

🌍💙This World Health Day 2025, let's work toward a future where quality healthcare is accessible to all. Stronger health systems start with innovation, and at Deep Bio, we're using AI to bridge gaps in medical needs. Join us in advocating for #HealthForAll #WorldHealthDay2025

Our new study published in Scientific Reports. Key Highlights: ✅AI-based Gleason grading&tumor quantification on 29,646WSIs from 992 patients analyzed with DeepDx Prostate-RP ✅High agreement with expert pathologists ✅Strong correlation between AI tumor quantification&prognosis

🚀 Deep Bio at #AACR2025 – Advancing AI in Cancer Diagnosis! Join us this April as we present AI-driven research in PD-L1 quantification, c-MET analysis & breast lymph node frozen sections. See DeepDx Prostate & DeepCDx in action! 📍 Booth #846 #AIinPathology #CancerResearch

Final Day at USCAP 2025 – Thank You from Deep Bio! 💡 A special thank you to everyone who visited our booth, stopped by our posters, and attended our podium presentations. ✈️ Safe travels to all, and we look forward to reconnecting at future events!

The first days of USCAP 2025 have been an incredible journey! 🎤 A huge thank you to everyone who attended our platform presentation and contributed to insightful discussions on AI-powered pathology solutions. Your engagement and expertise continue to push innovation forward!

🚀 Deep Bio is excited to present three groundbreaking AI-driven pathology studies at the 114th USCAP Annual Meeting in Boston! Our research showcases AI applications in breast, lung, and prostate cancer diagnostics, advancing digital pathology and precision medicine.

Join us at the 114th USCAP Annual Meeting in Boston from March 22-27! Experience DeepDx Prostate integrated with leading IMS platforms. Discover our exciting new features and connect with our specialists. Schedule a meeting using the QR code. We can't wait to see you there!

🎗️March is Cancer Awareness Month for Multiple Myeloma, Kidney, Anal & Colon Cancer. Early detection saves lives—raising awareness, research, & advanced diagnostics are key.🔬 Deep Bio is committed to AI-driven pathology solutions & research to enhance diagnostics & patient care.

Join us at the 114th Annual Meeting of USCAP! Visit Booth #511 for a live demo of our AI-driven solutions for Digital Pathology, including DeepDx Prostate, fully integrated into leading IMS platforms from Roche, PathAI, Visiopharm, Lumea, etc.

We’re excited to announce that Deep Bio researchers, in collaboration with Dr. Hong Koo Ha from the Dep. of Urology, PNUH, have contributed to a newly published review paper on AI in urological cancers in Prostate International!

🎗️ February: Gallbladder & Bile Duct Cancer Awareness Month This February, we shine a light on Gallbladder and Bile Duct Cancer, diseases that often go unnoticed but have a profound impact. 💪 Let’s make this month one of awareness, support, and advocacy for those affected.

🎗️World Cancer Day 2025 With a mission to transform cancer diagnostics through AI, Deep Bio equips pathologists with advanced tools for early detection. On this day, we stand united in the fight against cancer. 💙 Join us in raising awareness. #WorldCancerDay #AIforGood